Join
Live feed
·
PRReleasevia Quantisnow
Phio Pharmaceuticals Corp. logo

Phio Pharmaceuticals Announces Positive Pathology Results in Third Cohort in INTASYL PH-762 Skin Cancer Clinical Trial

ByQuantisnow·Wall Street's wire, on your screen.
PHIO· Phio Pharmaceuticals Corp.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PHIO (Phio Pharmaceuticals Corp.) and more on Quantisnow.